
Learn the Patello-femoral replacement: Smith and Nephew Journey implant surgical technique with step by step instructions on OrthOracle. Our e-learning platform contains high resolution images and a certified CME of the Patello-femoral replacement: Smith and Nephew Journey implant surgical procedure.
The indication for patello-femoral partial knee replacement is isolated arthritis of the patellofemoral joint (PFJ). This is often seen in conjunction with biomechanical abnormalities such as trochlea dysplasia, patella maltracking and patella alta in a relatively young age group, of people in their fifth decade, who require intervention with arthroplasty. An older subset of patients is also recognised less frequently have these associated biomechanics issues with their PFJ arthritis. The degenerative disease in older patients may start in the PFJ, and would eventually progress to a more generalised tricompartmental arthritis should their lifespan allow; until such time they remain suitable candidates for isolated patello-femoral replacement as the risk of progression is low given their age relative to likely life-expectancy .
The Journey patellofemoral replacement is a sided trochlea on-lay component which is produced in Oxinium to reduce wear and increase wetability. Oxinium is a trade name of a Smith and Nephew product used for joint reconstruction implants; it is oxidised zirconium as the ceramic surface of a transformed alloy through a patented process. This bearing surface is harder, more wettable and lighter than standard metal and has over ten years clinical experience. The use of Oxinium is a unique selling point for this implant with the potential benefits of longevity and better bio-integration on account of its biomechanics properties.
R.H. Zimlich, M. Levesque, W. Jones, H.D. Schutte, Jr., B.J. Livingston, W. Sauer, M. Spector, and K. Weaver, “In-vitro and in-vivo effect of particulate debris on TKA articulating surfaces”, scientific exhibit SE038, 65th Ann. Mtg. Am. Acad. Orthop. Surg., New Orleans, LA, March 19-23, 1998.
J. Fisher and D. Dowson, “Tribology of total artificial joints”, Proc. Instn. Mech. Engrs., 205 (H2), 1991, pp. 73-79.
The Journey Oxinium trochlea is paired with the Genesis II Patella which is produced and distributed in two forms: the three peg onlay and the single peg biconvex inlay design. Whilst both designs have long-term follow-up, my preference is for the inlay biconvex single peg component to allow fine-tuning of the patella (bone and polyethylene) thickness during the preparation steps as described in this technique.
My reason for using the Journey PFJ is a combination of familiarity with the Genesis II patella (being a Genesis user for total knee replacements) and the theoretical and laboratory suggested benefits of Oxinium to reduce wear and improve wetability.

INDICATIONS
Isolated arthritis of the patellofemoral joint (PFJ). This is often in conjunction with trochlea dysplasia, patella maltracking and patella alta. There is a bi-modal distribution of patient age for PFJ replacement in patellofemoral joint osteoarthritis (PFJOA) . Caution should be exercised with 60-75 year-old patients because their PFJ arthritis may progress into tricompartmental change. Patients in their 50s present early with PFJ arthritis because of a predisposing factors such as trochlear dysplasia or patella alta. In this age group progression of arthritis is unlikely because the predisposing bio-mechanical abnormality is treated with the patella femoral replacement.
In the elderly population it is acceptable to perform patella femoral replacement for isolated PFJ disease in the absence of a biomechanical abnormality as the chance of progression is relatively low due to likely patient lifetime survival.
SYMPTOMS & EXAMINATION
History
Patients complaining of generalised anterior pain in the knee. This is made worse by periods of inability with the knee flexed such as sitting in a confined space like a cinema seat or aircraft seat or back of a car. activities which load the patellofemoral joint will be more painful with post-activity swelling and stiffness. Classic aggravating activities include stairs (both ascent and descent but often with descent as the most problematic), squatting and kneeling. it is important to ask about personal history of adolescent knee pain including Osgood-Schlatter’s disease patella dislocation or patellofemoral overload often labelled as “Chondromalacia patellae”. In addition a family history should be sought as there are strong familial links to PFJ disease.
Examination
The examination should start with an assessment of walking follwed by a Trendelenberg and an attempt at squatting. there is classically an antalgic gate if there is a unilateral disease or a stiff knee gate and bilateral disease. Frequently there is proximal muscle weakness/poor gluteal recruitment Which may be assessed during gate pattern or on a Trendelenberg test. Personally I prefer to perform a Trendelenberg test (in this patient group) asking them to place their hands on the hips over the Iliac crests then standing on one leg at a time, observing pelvic tilt by inequality of hand position; if the abductors are weak in the standing leg then the opposite hand will drop down. During squats testing there is usually audible crepitus and the patient will be unable to proceed due to pain. Frequently patients will lean to their favourite side indicating which joint is most symptomatic.
Sitting examination is very useful to demonstrate patellofemoral height and tracking. in this position it is also prudent to rotate the hip to exclude any referred pain from the hip joint. The patella often starts laterally In full extension then moves medially as it engages in the trochlea before moving laterally again during deeper flexion. This is a reflection of a number of biomechanical abnormalities which are common in PFJ arthritis. The first of these to detect is patella alta where the patella is proximally positioned relative to the trochlea. Patients often describe this as having ‘knobbly knees’! I look for a positive ‘ski jump’ sign by running my hand distally down the quadriceps muscle and looking for a takeoff jump on the patella. Other techniques described for this include the three finger test for the distance between inferior pole and typical however this is very size dependent both for patient and examiner!
Supine examination should then be performed to detect effusion, Range of motion, localised areas of tenderness usually in the patellofemoral joint but not in the tibiofemoral joint line and irritability of the PFJ on compression testing – Clarks test. Caution is required here as this is often painful; I would suggest gently positioning the patella into the trochlear groove passively and should this be painful stopping the test at that stage, quadriceps activation only being required if the initial test is negative. A standard knee examination should be completed to exclude intra-articular pathology.
IMAGING
Plain x-rays including alignment views particularly looking for excessive valgus, skyline x-rays weight-bearing laterals and Rosenberg views should be performed both to demonstrateThe patellofemoral arthritis with loss of joint space but also to exclude any significant tibiofemoral joint space reduction.
MRI scan is very useful to demonstrate a well preserved medial and lateral joint as well as the localised PFJ arthritis and the patellofemoral indices. The presence of trochlea dysplasia, patella alta (evidenced by reduced patellotrochlea overlap) and bone loss in a worn dysplastic patella should be recorded. I prefer an MRI in addition to plain radiography.
ALTERNATIVE OPERATIVE TREATMENT
Total knee replacement is the standard treatment of end-stage knee arthritis including PFJ arthritis. In the largest RCT comparing PFJ arthroplasty to TKR (Odgard A et al CORR 2018) Isolated patella femoral replacement resulted in better patient reported outcomes and better range of movement than total knee replacement. however the reduced long-term survival rates found in the National Joint Registry must also be remembered and stringent patient selection adhered to.
In early disease it may be possible to perform tibial tubercle osteotomy to correct biomechanics (distalising and usually medialising) in addition to a subtle anteriorisation, by the direction of the ostoeotomy (posterolateral to anteromedial).
NON-OPERATIVE MANAGEMENT
Like all arthroplasty nonoperative treatment must be exhausted before proceeding to replacement. Careful physiotherapy assessment, gait re-education where appropriate and strengthening should be performed. consideration of shock absorbing insoles and walking aids as well as standard analgesic treatments.
CONTRAINDICATIONS
General absolute contraindications include active infection and medical comorbidities precluding arthroplasty.
Specific absolute contraindications include evidence of tibio-femoral arthritis.
Relative contraindications include patient age (60 to 75) and minor tibiofemoral chondral change or meniscal pathology where there is a risk of disease progression.

General anaesthesisa
Preoperative IV Antiobiotics
My personal preference is to avoid a tourniquet, but this certainly may be used according to surgeon preference.
Notice the position of the table within the operating theatre / room to allow all the sets sit with the laminar flow and maintaining the patient’s head, anaesthetist and assistant outside the laminar flow.
Side support and foot roll at approximately 90 degrees knee flexion, heels over the end of the bed, allowing for standing at the end of the table to assess component rotation.
Foot pump on the contra-lateral foot.
Social wash and then 2% chlorhexidine in alcohol preparation and standard draping with an exclusion U-drape, additional large drape around the end of the operating table and then a knee extremity drape. Exclusion draping with Ioban.

Over the last year we have changed PFJ arthroplasty into a day case or overnight stay procedure depending on the time of operating. Case performed in the morning or early afternoon tend to be day-case, whereas later afternoon and evening session cases stay in our Medirooms overnight – the equivalent of a day-case facility – and the are discharged first thing the following morning, allowing the mede-rooms to be available for the next-day’s patients.
Standard care postoperatively
Antibiotics: 24 hours prophylaxis – we use Flucloxacillin 1000mg x 3 postoperatively, in addition to the induction Flucloxacillin and Gentamycin on induction. The remaining doses (of the 24 hour schedule) on patient discharge are given orally as take-away medication.
Overnight stay or day case surgery.
Weight Bearing: full weight bear as soon as possible.
Bloods: Haemocue in revovery.
Radiograph: Anteroposterior and lateral XR
Dressing: Bulky wool compression bandage reduced at 12 hours and replaced with a single tubigrip.
Dressing: occlusive dressing left in situ for 2 weeks, ideally undisturbed from theatre, but changed on the rare occasions that the wound leaks.
Venous thromboembolism prophylaxis: Aspirin 150mg for 6 weeks orally for standard risk. Patients with previous VTE receive 10 days of low molecular weight heparin (LMWH) in addition to their Aspirin. Patients on prophylactic long term anticoagulants including NOACs should simply return to their normal medication on day 2, using LMWH at prophylactic dose on day 1.
Follow-up – depending on the patient’s functional ability we usually ask them to remove their own dressing at 2 weeks, but where this is impractical we review in our outpatient department at 2 weeks. Subsequent review is scheduled as: 6-8 weeks, 12 months, 2 years, 7, 10,13 years continuing every 3 years as per UK National Guidance
Variance – Any concerns with the wound should trigger a review by the treating surgical team and must not be managed in the community.

There are limited results for any patellofemoral replacement system.
At a mean of seven years we found an 88% survival of implants and good patient satisfaction.
Knee. 2016 Oct;23(5):900-4. doi: 10.1016/j.knee.2016.03.004 .The Journey patellofemoral joint arthroplasty: A minimum 5year follow-up study.
Ahearn N, Metcalfe AJ, Hassaballa MA, Porteous AJ, Robinson JR, Murray JR, Newman JH.
Knee. 2016 Oct;23(5):900-4. doi: 10.1016/j.knee.2016.03.004 .The Journey patellofemoral joint arthroplasty: A minimum 5year follow-up study.
Ahearn N, Metcalfe AJ, Hassaballa MA, Porteous AJ, Robinson JR, Murray JR, Newman JH.
As a comparison using the Avon PFJ replacement the implant survival was 77% at 10 years and 67% at 15 years.
Bone Joint J. 2018 Sep;100-B(9):1162-1167. doi: 10.1302/0301-620X.100B9.BJJ-2018-0174.R1. The Avon patellofemoral joint arthroplasty: two- to 18-year results of a large single-centre cohort.
Metcalfe AJ, Ahearn N, Hassaballa MA, Parsons N, Ackroyd CE, Murray JR, Robinson JR, Eldridge JD, Porteous AJ.
Reference
- orthoracle.com






























































































